SAN DIEGO (AP) — SAN DIEGO (AP) — Telesis Bio, Inc. (TBIO) on Thursday reported a loss of $6.6 million in its third quarter.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

AnaptysBio (NASDAQ:ANAB), which is advancing an arthritis therapy similar to Eli Lilly's (NYSE:LLY) PD-1 agonist peresolimab, sold off in the premarket on Wednesday after the Indiana-based pharma ...

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through ...

Alternatives to petrochemical-based plastics are emerging, made from everything from banana leaves to tomato skins, especially for food packaging. But questions remain about how biodegradable and ...

Spirit Airlines (NK, Fort Lauderdale International) has entered into a binding term sheet with GA Telesis to sell twenty-three A320 and A321 types, according to an October 24 Securities Exchange ...

This page features the latest news about the Telesis Bio stock. Telesis Bio announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions ...

integration of automation in dna synthesis. However, regulatory issues associated with dna synthesis therapeutics poses a challenge. Key market players include Azenta US, Inc, Bio Basic Inc ...

25, 2024 (GLOBE NEWSWIRE) -- A new partnership between Telesis Bio and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, will create efficient and scalable ...